RESPIRATORY DISORDER NEONATAL

This adverse event was reported 1622 times

These drugs are most commonly taken by patients reporting RESPIRATORY DISORDER NEONATAL:

# Drug Count
0 QUETIAPINE 242
1 VENLAFAXINE HYDROCHLORIDE 230
2 VENLAFAXINE 216
3 SERTRALINE 214
4 CITALOPRAM 204
5 CITALOPRAM HYDROBROMIDE 201
6 LAMOTRIGINE 158
7 LAMOTIRIGINE 141
8 LAMOTRIGINE CHEWABLE DISPERSIBLE 141
9 LAMOTRIGINE EXTENDED-RELEASE 141
See all common drugs associated with RESPIRATORY DISORDER NEONATAL

RESPIRATORY DISORDER NEONATAL is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 METHYLDOPA 45 0.0091
1 ILOPROST 8 0.0086
2 HUMAN RHO(D) IMMUNE GLOBULIN 7 0.0068
3 OXYTOCIN 19 0.0062
4 DINOPROSTONE 5 0.0061
5 MISOPROSTOL 50 0.0051
6 NARATRIPTAN 6 0.0043
7 AMPICILLIN INJECTION 27 0.0036
8 AMPICILLIN 28 0.0034
9 PROPAFENONE 9 0.0021
See all drugs enriched for association with RESPIRATORY DISORDER NEONATAL

RESPIRATORY DISORDER NEONATAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Prostacycline [EPC] 8 0.0086
1 Oxytocic [EPC] 19 0.0062
2 Surfactant [EPC] 5 0.0043
3 Prostaglandin E1 Analog [EPC] 50 0.0030
4 Serotonin Reuptake Inhibitor [EPC] 194 0.0022
5 Opioid Antagonist [EPC] 2 0.0021
6 Progesterone [EPC] 42 0.0018
7 Blood Viscosity Reducer [EPC] 7 0.0016
8 Anti-epileptic Agent [EPC] 199 0.0009
9 Cannabinoid [EPC] 7 0.0009
See all drug classes enriched for association with RESPIRATORY DISORDER NEONATAL